deltatrials
Completed PHASE4 INTERVENTIONAL 1-arm NCT00815282

Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease (HPV-kind)

Sponsor: N.M. Wulffraat

Conditions Juvenile Dermatomyositis Juvenile Idiopathic Arthritis Systemic Lupus Erythematosus
Interventions Human papilloma virus vaccine (cervarix)
Updated 6 times since 2017 Last updated: Nov 8, 2017 Started: Feb 28, 2009 Primary completion: Jan 31, 2015 Completion: Jan 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00815282, this PHASE4 trial focuses on Juvenile Dermatomyositis and Juvenile Idiopathic Arthritis and remains completed. Sponsored by N.M. Wulffraat, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Dec 2017 · 11 months · monthly snapshotUnknown Status~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Dec 2017 — Jun 2018 [monthly]

    Completed PHASE4

    Status: Unknown Status → Completed

▶ Show 1 earlier version

  1. Jan 2017 — Dec 2017 [monthly]

    Unknown Status PHASE4

    First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • N.M. Wulffraat
  • National Institute for Public Health and the Environment (RIVM)
Data source: UMC Utrecht

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations